Trial Profile
Study of RV3-BB human neonatal rotavirus vaccine in Indonesia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Aug 2018
Price :
$35
*
At a glance
- Drugs AM94 (Primary)
- Indications Rotavirus infections
- Focus Therapeutic Use
- 31 Aug 2018 New trial record
- 22 Aug 2018 Results published in the Vaccine